People - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

People
People on the move.

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 3, Issue 6

Duessoldorf, Germany (June 5)–The supervisory board of Degussa GmbH named Patrik Wohlhauser, currently head of the exclusive synthesis & catalysts business unit, as an executive director of Degussa GmbH. From July 1, 2007, his new responsibilities will include, among others, the new international sales function of RAG's subsidiary Degussa. Wohlhauser will also be the management board member responsible for the Consumer Solutions reporting segment and for the Western and Eastern Europe regions. His successor as head of the exclusive synthesis & catalysts business unit will be Rudolf Hanko, who currently heads the exclusive synthesis business line of the same business unit.

San Diego, CA (June 5)Cadence Pharmaceuticals, Inc appointed Catherine J. Hardalo, MD, vice-president of clinical development. Hardalo joins the company from Schering-Plough Research Institute, where she directed the clinical development of antimicrobial products.

San Diego, CA (June 4)–Carol G. Gallagher was promoted to senior vice-president of corporate development and commercial affairs with Anadys Pharmaceuticals, Inc. Gallagher joined the company as vice-president of commercial affairs in April 2006. She previously served as vice-president of sales, marketing, and product planning at CancerVax Corporation and senior director of oncology marketing at Biogen Idec, Inc.

Emeryville, CA (May 31)Bionovo, Inc. named Rob Frankenberg, PhD, vice-president of drug manufacturing. Frankenberg joins the company after serving in various positions with Bayer HealthCare.

Mississauga, ON, Canada (May 29)Draxis Pharma named Bruce DeChambre vice-president of commercial and business development. DeChambre previously was vice-president of sales and marketing at SAB-Pharma. He also held positions at Abraxis Pharmaceutical, Fujisawa USA, Inc., and Baxter Healthcare Corp.

Irvine, CA (May 29)–Timothy P. Walbert was named chief executive officer of IDM Pharma. Walbert previously was executive vice-president, commercial operations with NeoPharm, Inc.

Indianapolis, IN (May 25)Eli Lilly and Co. promoted Frank Deane to president of manufacturing. Deane is currently vice-president of quality. He joined Lilly in 1979 at the company's manufacturing operations in Kinsale, Ireland.

Burlington, MA (May 24)–Robert M. Haggerty was appointed vice-president of quality with Hyaluron Contract Manufacturing. Haggerty served as director of quality assurance at Alexion Pharmaceuticals and held various positions at Ben Venue, Dupont, and Transkaryotic Therapies.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here